TrialPeritoneal dialysis international : journal of the International Society for Peritoneal Dialysis

Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients--a randomized crossover trial.

Yun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.